- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 51M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2024 | 50.97M sh |
| Capex | Q1 2026 · Sep 30, 2025 | $345K |
| Capex | Q1 2026 · Sep 30, 2024 | $10K |
| Operating Cash Flow | Q1 2026 · Sep 30, 2025 | $2.72M |
| Operating Cash Flow restated | Q1 2026 · Sep 30, 2024 | −$11.64M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $108.13M |
| Stockholders Equity | Q1 2026 · Jun 30, 2025 | $103.22M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | $88.03M |
| Stockholders Equity | Q1 2026 · Jun 30, 2024 | $87.63M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $189.03M |
| Current Liabilities | Q1 2026 · Jun 30, 2025 | $172.73M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $274.86M |
| Total Liabilities | Q1 2026 · Jun 30, 2025 | $258.01M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $242.23M |
| Current Assets | Q1 2026 · Jun 30, 2025 | $218.13M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $382.99M |
| Total Assets | Q1 2026 · Jun 30, 2025 | $361.23M |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | $0.10 |
| Eps Diluted | Q1 2026 · Sep 30, 2024 | $0.01 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | $0.10 |
| Eps Basic | Q1 2026 · Sep 30, 2024 | $0.01 |
| Sga Expense | Q1 2026 · Sep 30, 2025 | $15.08M |
| Sga Expense restated | Q1 2026 · Sep 30, 2024 | $13.1M |
| Net Income | Q1 2026 · Sep 30, 2025 | $4.88M |
| Net Income | Q1 2026 · Sep 30, 2024 | $397K |
| Operating Income | Q1 2026 · Sep 30, 2025 | $10.55M |
| Operating Income restated | Q1 2026 · Sep 30, 2024 | $2.12M |
| Revenue | Q1 2026 · Sep 30, 2025 | $253.97M |
| Revenue | Q1 2026 · Sep 30, 2024 | $228.99M |